COVID-19 clinical trials: who is likely to participate and why?
J Comp Eff Res
; 13(8): e230181, 2024 Aug.
Article
en En
| MEDLINE
| ID: mdl-39045844
ABSTRACT
Aim:
To identify factors associated with willingness to participate in a COVID-19 clinical trial and reasons for and against participating. Materials &methods:
We surveyed Massachusetts (MA, USA) residents online using the Dynata survey platform and via phone using random digit dialing between October and November 2021. Respondents were asked to imagine they were hospitalized with COVID-19 and invited to participate in a treatment trial. We assessed willingness to participate by asking, "Which way are you leaning" and why. We used multivariate logistic regression to model factors associated with leaning toward participation. Open-ended responses were analyzed using conventional content analysis.Results:
Of 1071 respondents, 65.6% leaned toward participating. Multivariable analyses revealed college-education (OR 1.59; 95% CI 1.11, 2.27), trust in the healthcare system (OR 1.32; 95% CI 1.10, 1.58) and relying on doctors (OR 1.77; 95% CI 1.45, 2.17) and family or friends (OR 1.31; 95% CI 1.11, 1.54) to make health decisions were significantly associated with leaning toward participating. Respondents with lower health literacy (OR 0.57; 95% CI 0.36, 0.91) and who identify as Black (OR 0.40; 95% CI 0.24, 0.68), Hispanic (OR 0.61; 95% CI 0.38, 0.98), or republican (OR 0.61; 95% CI 0.38, 0.97) were significantly less likely to lean toward participating. Common reasons for participating included helping others, benefitting oneself and deeming the study low risk. Common reasons for leaning against were deeming the study high risk, disliking experimental treatments and not wanting to be a guinea pig.Conclusion:
Our finding that vulnerable individuals and those with lower levels of trust in the healthcare system are less likely to be receptive to participating in a COVID-19 clinical trial highlights that work is needed to achieve a healthcare system that provides confidence to historically disadvantaged groups that their participation in research will benefit their community.Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Ensayos Clínicos como Asunto
/
COVID-19
Límite:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
País/Región como asunto:
America do norte
Idioma:
En
Revista:
J Comp Eff Res
Año:
2024
Tipo del documento:
Article
País de afiliación:
Estados Unidos
Pais de publicación:
Reino Unido